
Pharma Pulse 10/8/24: Blending Models for Better Sourcing Solutions, Money Spent on Healthcare Doesn’t Provide Value & more
The latest news for pharma industry insiders.
In the new age of sourcing, sponsors are looking beyond the conventional outsourcing or insourcing categories, collaborating with clinical research organizations (CROs) on bespoke solutions that deliver on their unique needs. There is a growing trend among large and midsize pharma in turning toward more strategic partnerships to help them navigate the increasing complexity of the development landscape and the compounding macroeconomic constraints.
Sanjula Jain of Trilliant Health talks about how employers are best positioned to demand value for money from the U.S. healthcare system.
Blackstone and TikTok’s parent are among those investing in data centers in Malaysia’s Johor, known for palm-oil plantations.
Stenta will lead B2B commercial growth strategy as the company strengthens its role as the first choice for community pharmacy and health services in the U.S.
In a recent interview with Pharmaceutical Executive, our founder & CEO Peter Ax and COO George Jones discussed how we take rigorous steps to guarantee the authenticity of our medications at UpScriptHealth. From sourcing only FDA-approved treatments to implementing robust supply chain protocols, we are committed to providing quality medications for our patients.
https://lnkd.in/gSsgbEGU
#Telehealth #PatientSafety #PharmaExec
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

